This article serves as a formal correction to the research paper titled "Neuroblastoma with high ASPM reveals pronounced heterogeneity and poor prognosis," originally published by Li et al. (2024). The correction addresses specific administrative and bibliographic omissions that occurred during the publication process, ensuring the scientific record accurately reflects the contributions of the research team and the methodology employed.
Context of the Original Study
The original research addresses a critical challenge in pediatric oncology: predicting clinical outcomes for patients with neuroblastoma. The study identifies the ASPM (Abnormal Spindle-like Microcephaly-associated) gene as a significant biomarker. High expression levels of ASPM were found to correlate with poor patient prognosis and increased tumor heterogeneity.
To quantify this heterogeneity, the researchers bridged molecular biology with clinical imaging through the field of radiomics. By analyzing medical imaging (such as PET, CT, or MRI scans), the team sought to identify physical manifestations of the tumor's genetic profile, providing a non-invasive method to assess disease severity.
Details of the Correction
The correction notice rectifies two primary issues:
1. Authorship Update
Due to a typesetting error in the original publication, the authorship roles were not fully represented. This notice officially restores Suyun Chen as a co-corresponding author of the study, acknowledging their essential leadership and contribution to the research.
2. Software Citation and Reproducibility
A key technical component of the study involved the segmentation and selection of radiomic features. The original text failed to include the formal citation for the software used for these calculations. The authors have now added a reference to LIFEx, a freeware tool specifically designed for radiomic feature calculation in multimodality imaging.
- Added Reference: Nioche C, Orlhac F, Boughdad S, Reuzé S, Goya-Outi J, Robert C, Pellot C, Abbas M, Buvat I. LIFEx: A Freeware for Radiomic Feature Extraction in Multimodality Imaging to Accelerate Medical Research. Cancer Res. 2018;78(16):4786–9.
Significance of the Update
While the fundamental scientific conclusions regarding ASPM and neuroblastoma remain unchanged, these corrections are vital for the integrity of the work. Properly attributing authorship ensures academic accountability, while the inclusion of the LIFEx citation provides the necessary transparency for other researchers to replicate the study’s radiomic analysis. The original article has been updated to reflect these changes.
Summary updated